tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
PDS Biotechnology Corporation (PDSB)
NASDAQ:PDSB
US Market
PDSB
PDS Biotechnology
Overview
Analyst Forecasts
AI Stock Analysis
News & Insights
Financials
Dividends
Technical Analysis
Options
Chart
Earnings
Ownership
Historical Prices
Stock Buybacks
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

PDS Biotechnology (PDSB) Stock News & Sentiment

Compare
711 Followers
PDS Biotech’s Earnings Call Highlights: Clinical Progress Amid Funding Challenges
Premium
Company Announcements
PDS Biotech’s Earnings Call Highlights: Clinical Progress Amid Funding Challenges
7d ago
PDSB
PDS Biotechnology Advances Cancer Immunotherapy Trials
Premium
Company Announcements
PDS Biotechnology Advances Cancer Immunotherapy Trials
8d ago
PDSB
Options Volatility and Implied Earnings Moves Today, March 27, 2025
Premium
Market News
Options Volatility and Implied Earnings Moves Today, March 27, 2025
9d ago
SNX
WGO
PDSB Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
PDSB Earnings this Week: How Will it Perform?
11d ago
PDSB
PDS Biotechnology’s Promising Phase 3 Trial and Strong Clinical Foundation Justify Buy Rating
Premium
Ratings
PDS Biotechnology’s Promising Phase 3 Trial and Strong Clinical Foundation Justify Buy Rating
28d ago
PDSB
Promising Efficacy of PDS Biotechnology’s Versamune Platform in Cervical Cancer Treatment Drives Buy Rating
Premium
Ratings
Promising Efficacy of PDS Biotechnology’s Versamune Platform in Cervical Cancer Treatment Drives Buy Rating
1M ago
PDSB
PDS Biotechnology Highlights Clinical Progress and Q3 Results
Premium
Company Announcements
PDS Biotechnology Highlights Clinical Progress and Q3 Results
5M ago
PDSB
More PDSB News >

PDSB News on the Web

PDS Biotechnology Corp (PDSB) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...
GuruFocus News
Neutral
Q4 2024 PDS Biotechnology Corp Earnings Call Transcript
GuruFocus News
Neutral
PDS Biotechnology Advances Cancer Immunotherapy Trials
TipRanks News
Neutral
PDS Biotechnology commences trial for head and neck squamous cell carcinoma
Clinical Trials Arena
Neutral
PDS Biotech Initiates VERSATILE-003 Phase 3 Clinical Trial Evaluating Versamune® HPV in HPV16-Positive Head and Neck Cancer
Yahoo Finance
Neutral
PDS Biotech Announces Circulating Tumor DNA Results for Versamune® HPV in IMMUNOCERV Trial Published in Clinical Cancer Research
Yahoo Finance
Neutral
PDS Biotech Reaffirms Guidance for First Quarter Initiation of VERSATILE-003 Phase 3 Clinical Trial in HPV16-Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Yahoo Finance
Neutral
Down -35.74% in 4 Weeks, Here's Why PDS Biotechnology (PDSB) Looks Ripe for a Turnaround
Zacks
Neutral

News Score - Last 7 Days

Neutral
PDSB
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week59%
Sector Average59%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PDSB’s Media Buzz Sentiment?
Currently, no data Available
What is PDSB’s weekly average amount of articles?
Currently, no data Available
What is PDSB’s News Sentiment?
59% of articles about PDSB were positive this week, compared to its sector average of 59%.
    Healthcare Stocks that are Trending in the News
    GRIGRI Bio
    SLPSimulations Plus
    CORTCorcept Therapeutics
    LFCRLifecore Biomedical
    HAWPFHaw Par
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing